Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
<![CDATA[Arcutis’ 2026 Pipeline Expansion into Vitiligo, HS, and Systemic Biologics]]>

<![CDATA[Arcutis’ 2026 Pipeline Expansion into Vitiligo, HS, and Systemic Biologics]]>

Neutral Dermatology Times
Owner: Mike Hennessy Jr.
COVID-19 pandemic narrowed healthcare industry pay gap, new study finds

COVID-19 pandemic narrowed healthcare industry pay gap, new study finds

COVID-19 pandemic narrowed health industry pay gap

COVID-19 pandemic narrowed health industry pay gap

BSI launches a world-first environmental standard for the pharma industry

BSI launches a world-first environmental standard for the pharma industry

10 Healthcare Industry Predictions For 2026

10 Healthcare Industry Predictions For 2026

Unpacking PHARMAP 2026: Advanced Technologies and Solutions for the Industry

Unpacking PHARMAP 2026: Advanced Technologies and Solutions for the Industry

<![CDATA[Simplified Packaging Increases Adherence to Type 2 Diabetes Therapy]]>

<![CDATA[Simplified Packaging Increases Adherence to Type 2 Diabetes Therapy]]>

<![CDATA[JANX007 Displays Encouraging Safety/Efficacy in Metastatic CRPC]]>

<![CDATA[JANX007 Displays Encouraging Safety/Efficacy in Metastatic CRPC]]>

Kiora Pharmaceuticals Secures New U.S. Patent for Novel KIO-100 Formulations

Kiora Pharmaceuticals Secures New U.S. Patent for Novel KIO-100 Formulations

<![CDATA[Childhood Vaccines Could Alleviate Significant Rise in CAP Hospitalizations]]>

<![CDATA[Childhood Vaccines Could Alleviate Significant Rise in CAP Hospitalizations]]>

<![CDATA[Celltrion’s EYLEA-referencing biosimilar, EYDENZELT, receives Canadian approval]]>

<![CDATA[Celltrion’s EYLEA-referencing biosimilar, EYDENZELT, receives Canadian approval]]>

Indeterminate Ophthalmology Times Europe
Owner: Mike Hennessy Jr.
COVID-19 pandemic narrowed healthcare industry pay gap, new study finds

COVID-19 pandemic narrowed healthcare industry pay gap, new study finds

COVID-19 pandemic narrowed health industry pay gap

COVID-19 pandemic narrowed health industry pay gap

BSI launches a world-first environmental standard for the pharma industry

BSI launches a world-first environmental standard for the pharma industry

10 Healthcare Industry Predictions For 2026

10 Healthcare Industry Predictions For 2026

Unpacking PHARMAP 2026: Advanced Technologies and Solutions for the Industry

Unpacking PHARMAP 2026: Advanced Technologies and Solutions for the Industry

<![CDATA[Simplified Packaging Increases Adherence to Type 2 Diabetes Therapy]]>

<![CDATA[Simplified Packaging Increases Adherence to Type 2 Diabetes Therapy]]>

<![CDATA[JANX007 Displays Encouraging Safety/Efficacy in Metastatic CRPC]]>

<![CDATA[JANX007 Displays Encouraging Safety/Efficacy in Metastatic CRPC]]>

Kiora Pharmaceuticals Secures New U.S. Patent for Novel KIO-100 Formulations

Kiora Pharmaceuticals Secures New U.S. Patent for Novel KIO-100 Formulations

<![CDATA[Childhood Vaccines Could Alleviate Significant Rise in CAP Hospitalizations]]>

<![CDATA[Childhood Vaccines Could Alleviate Significant Rise in CAP Hospitalizations]]>

<![CDATA[Celltrion’s EYLEA-referencing biosimilar, EYDENZELT, receives Canadian approval]]>

<![CDATA[Celltrion’s EYLEA-referencing biosimilar, EYDENZELT, receives Canadian approval]]>

<![CDATA[Arcutis’ 2026 Pipeline Expansion into Vitiligo, HS, and Systemic Biologics]]>

<![CDATA[Arcutis’ 2026 Pipeline Expansion into Vitiligo, HS, and Systemic Biologics]]>

Show More

Video Stories

YouTube video thumbnail: Trump Declines to Mark World Aids Day as Funding Cuts Threaten HIV-Prevention Efforts
Play
Trump Declines to Mark World Aids Day as Funding Cuts Threaten HIV-Prevention Efforts
YouTube video thumbnail: Remote Robot Procedure Heralds a new era of Brain Surgery
Play
Remote Robot Procedure Heralds a new era of Brain Surgery
YouTube video thumbnail: Measles Vaccination Drive Expands in East of Drcongo as Conflict Displacement Fuels Outbreak
Play
Measles Vaccination Drive Expands in East of Drcongo as Conflict Displacement Fuels Outbreak
YouTube video thumbnail: What Are Forever Chemicals, and How Do They Impact Our Health?
Play
What Are Forever Chemicals, and How Do They Impact Our Health?

Video Title

Press Releases

Ten changes to transform mental health research

Ten changes to transform mental health research

“A problem shared is a problem halved” – Joshua’s story

“A problem shared is a problem halved” – Joshua’s story

Attor­ney Gen­er­al Pax­ton Sues Big Phar­ma Com­pa­nies Bris­tol-Myers Squibb and Sanofi for Mak­ing Bil­lions While Harm­ing Amer­i­cans and Fail­ing to Dis­close Plavix’s Ineffectiveness

Attor­ney Gen­er­al Pax­ton Sues Big Phar­ma Com­pa­nies Bris­tol-Myers Squibb and Sanofi for Mak­ing Bil­lions While Harm­ing Amer­i­cans and Fail­ing to Dis­close Plavix’s Ineffectiveness

Ten changes to transform mental health research

Ten changes to transform mental health research

“A problem shared is a problem halved” – Joshua’s story

“A problem shared is a problem halved” – Joshua’s story

Attor­ney Gen­er­al Pax­ton Sues Big Phar­ma Com­pa­nies Bris­tol-Myers Squibb and Sanofi for Mak­ing Bil­lions While Harm­ing Amer­i­cans and Fail­ing to Dis­close Plavix’s Ineffectiveness

Attor­ney Gen­er­al Pax­ton Sues Big Phar­ma Com­pa­nies Bris­tol-Myers Squibb and Sanofi for Mak­ing Bil­lions While Harm­ing Amer­i­cans and Fail­ing to Dis­close Plavix’s Ineffectiveness

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions